Prostate Volume Changes Over Time: Results From the Baltimore Longitudinal Study of Aging

Journal of Urology

Volumn 182, Issue 4 SUPPL., 2009, Pages 1458-1462

  Loeb, Stacy ^a   Kettermann, Anna ^a   Carter, H Ballentine ^a   Ferrucci, Luigi ^b   Metter, E Jeffrey ^b   Walsh, Patrick C ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

atrophy; longitudinal studies; organ size; prostate; prostatic hyperplasia

Indexed keywords

TESTOSTERONE;

ADULT; AGED; AGING; ARTICLE; GROWTH RATE; HUMAN; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; PROSTATE SIZE;

ADULT; AGE FACTORS; AGED; AGING; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ORGAN SIZE; PROSTATE; TIME FACTORS;

EID: 69749086127     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.06.047     Document Type: Article

References (16)

1. Berry S.J., Coffey D.S., Walsh P.C., et al. The development of human benign prostatic hyperplasia with age. J Urol 132 (1984) 474
2. Wei J.T., Calhoun E., and Jacobsen S.J. Urologic Diseases in America Project: benign prostatic hyperplasia. J Urol 179 (2008) S75
3. Tempany C.M., Partin A.W., Zerhouni E.A., et al. The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia. Prostate 22 (1993) 39
4. Kaplan S.A., McConnell J.D., Roehrborn C.G., et al. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater. J Urol 175 (2006) 217
5. Roehrborn C.G., McConnell J.D., Lieber M., et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology 53 (1999) 473
6. St. Sauver J.L., Jacobson D.J., Girman C.J., et al. Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort. J Urol 175 (2006) 1018
7. Williams A.M., Simon I., Landis P.K., et al. Prostatic growth rate determined from MRI data: age-related longitudinal changes. J Androl 20 (1999) 474
8. Carter H.B., Pearson J.D., Metter E.J., et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267 (1992) 2215
9. Parsons J.K., Carter H.B., Platz E.A., et al. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiol Biomarkers Prev 14 (2005) 2257
10. Swyer G.I. Post-natal growth changes in the human prostate. J Anat 78 (1944) 130
11. Tsukamoto T., Masumori N., Rahman M., et al. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally. Int J Urol 14 (2007) 321
12. Bosch J.L., Tilling K., Bohnen A.M., et al. Establishing normal reference ranges for prostate volume change with age in the population-based Krimpen-study: prediction of future prostate volume in individual men. Prostate 67 (2007) 1816
13. Rhodes T., Girman C.J., Jacobsen S.J., et al. Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old. J Urol 161 (1999) 1174
14. Wright E.J., Fang J., Metter E.J., et al. Prostate specific antigen predicts the long-term risk of prostate enlargement: results from the Baltimore Longitudinal Study of Aging. J Urol 167 (2002) 2484
15. al-Rimawi M., Griffiths D.J., Boake R.C., et al. Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostatic volume. Br J Urol 74 (1994) 596
16. Rahmouni A., Yang A., Tempany C.M., et al. Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr 16 (1992) 935